In addition, a dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) co-agonist, tirzepatide, has been recently developed for the treatment of type 2 diabetes and obesity (Jakubowska et al., 2024)
About the author Our resident Leeds lass, Rebecca Roberts is a Senior Content Editor here at Mumsnet
And, carefully monitor your blood glucose levels regularly when taking this medication
Moreover, null or inconsistent findings in some mechanistic trials, including absent changes in certain satiety hormones or mixed reward-response patterns, underscore the complexity of these pathways
Janet K
Do not blow on the site or fan it with your hand, as this can introduce bacteria